Derivation of myogenic progenitors directly from human pluripotent stem cells using a sphere-based Culture

Stem Cells Translational Medicine

Volumn 3, Issue 5, 2014, Pages 564-574

  Hosoyama, Tohru ^a   McGivern, Jered V ^b   Van Dyke, Jonathan M ^a   Ebert, Allison D ^b   Suzuki, Masatoshi ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Amyotrophic lateral sclerosis; Embryonic stem cells; Induced pluripotent stem cells; Muscular dystrophy; Skeletal muscle; Spinal muscular atrophy

Indexed keywords

BETA ACTIN; COPPER ZINC SUPEROXIDE DISMUTASE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; KI 67 ANTIGEN; MESSENGER RNA; MYOD PROTEIN; MYOGENIC FACTOR 5; MYOGENIN; SYNAPTOBREVIN; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX7;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BECKER MUSCULAR DYSTROPHY; CELL DIFFERENTIATION; CELL POPULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DONOR; EMBRYONIC STEM CELL; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN PLURIPOTENT STEM CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; KARYOTYPING; MAJOR HISTOCOMPATIBILITY COMPLEX; MUSCLE ATROPHY; MUSCLE DEVELOPMENT; MYOGENIC PROGENITOR; MYOTUBE; NEURAL STEM CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SKELETAL MUSCLE; SPHERE BASED CULTURE; SPINAL MUSCULAR ATROPHY; STEM CELL; STEM CELL CULTURE; STEM CELL TRANSPLANTATION;

AMYOTROPHIC LATERAL SCLEROSIS; EMBRYONIC STEM CELLS; INDUCED PLURIPOTENT STEM CELLS; MUSCULAR DYSTROPHY; SKELETAL MUSCLE; SPINAL MUSCULAR ATROPHY;

CELL DIFFERENTIATION; CELL LINE; EMBRYONIC STEM CELLS; FIBROBLAST GROWTH FACTOR 2; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MUSCLE DEVELOPMENT; MUSCLE FIBERS, SKELETAL; NEUROMUSCULAR DISEASES; SPHEROIDS, CELLULAR; STEM CELL TRANSPLANTATION;

EID: 84899668462     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2013-0143     Document Type: Article

References (43)

1. Hosoyama T, Van Dyke J, Suzuki M. Applications of skeletal muscle progenitor cells for neuromuscular diseases. Am J Stem Cells 2012;1:253-263.
2. Tedesco FS, Cossu G. Stem cell therapies for muscle disorders. Curr Opin Neurol 2012; 25:597-603.
3. Salani S, Donadoni C, Rizzo F et al. Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies. J Cell Mol Med 2012;16: 1353-1364.
4. Rao L, Tang W, Wei Y et al. Highly efficient derivation of skeletal myotubes from human embryonic stem cells. Stem Cell Rev 2012;8: 1109-1119.
5. Barberi T, Bradbury M, Dincer Z et al. Derivation of engraftable skeletal myoblasts from human embryonic stem cells. Nat Med 2007; 13:642-648.
6. Awaya T, Kato T, Mizuno Y et al. Selective development ofmyogenicmesenchymal cells from human embryonic and induced pluripotent stem cells. PLoS One 2012;7: e51638.
7. Darabi R, Gehlbach K, Bachoo RM et al. Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nat Med 2008;14:134-143.
8. Darabi R, Santos FN, Filareto A et al. Assessment of the myogenic stem cell compartment following transplantation of Pax3/ Pax7-induced embryonic stem cell-derived progenitors. STEM CELLS 2011;29:777-790.
9. Darabi R, Arpke RW, Irion S et al. Human ES-and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice. Cell Stem Cell 2012;10:610-619.
10. HD iPSC Consortium. Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansionassociated phenotypes. Cell Stem Cell 2012; 11:264-278.
11. Ebert AD, Yu J, Rose FF Jr. et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009;457:277-280.
12. Ebert AD, Shelley BC, Hurley AM et al. EZ spheres: A stable and expandable culture system for the generation of pre-rosette multipotent stem cells from human ESCs and iPSCs. Stem Cell Res (Amst) 2013;10: 417-427.
13. Sareen D, Ebert AD, Heins BM et al. Inhibition of apoptosis blocks human motor neuron cell death in a stem cell model of spinal muscular atrophy. PLoS One 2012;7:e39113.
14. Tamaki T, Akatsuka A, Okada Y et al. Growth and differentiation potential of main-and side-population cells derived from murine skeletal muscle. Exp Cell Res 2003; 291:83-90.
15. Tamaki T, Okada Y, Uchiyama Y et al. Skeletal muscle-derived CD34+/45-and CD34-/45-stem cells are situated hierarchically upstream of Pax7+ cells. Stem Cells Dev 2008;17:653-667.
16. Hosoyama T, Meyer MG, Krakora D et al. Isolation and in vitro propagation of human skeletal muscle progenitor cells from fetal muscle. Cell Biol Int 2013;37:191-196.
17. Sarig R, Baruchi Z, FuchsOet al. Regeneration and transdifferentiation potential of muscle-derived stem cells propagated as myospheres. STEM CELLS 2006;24:1769-1778.
18. Wei Y, Li Y, Chen C et al. Human skeletal muscle-derived stem cells retain stem cell properties after expansion in myosphere culture. Exp Cell Res 2011;317: 1016-1027.
19. Westerman KA, Penvose A, Yang Z et al. Adult muscle "stem" cells can be sustained in culture as free-floating myospheres. Exp Cell Res 2010;316:1966-1976.
20. Park IH, Arora N, Huo H et al. Diseasespecific induced pluripotent stem cells. Cell 2008;134:877-886.
21. Mitne-Neto M, Machado-Costa M, Marchetto MC et al. Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients. Hum Mol Genet 2011;20:3642-3652.
22. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318: 1917-1920.
23. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282: 1145-1147.
24. Ludwig TE, Bergendahl V, Levenstein ME et al. Feeder-independent culture of human embryonic stem cells. Nat Methods 2006;3: 637-646.
25. Ludwig TE, Levenstein ME, Jones JMet al. Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 2006;24: 185-187.
26. Svendsen CN, ter Borg MG, Armstrong RJ et al. A new method for the rapid and long term growth of human neural precursor cells. J Neurosci Methods 1998;85:141-152.
27. Nelson AD, Suzuki M, Svendsen CN. A high concentration of epidermal growth factor increases the growth and survival of neurogenic radial glial cells within human neurosphere cultures. STEM CELLS 2008;26: 348-355.
28. Nelson AD, Svendsen CN. Low concentrations of extracellular FGF-2 are sufficient but not essential for neurogenesis from human neural progenitor cells. Mol Cell Neurosci 2006;33:29-35.
29. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676.
30. Takahashi K, Tanabe K, OhnukiMet al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-872.
31. Park IH, Zhao R, West JA et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008;451: 141-146.
32. Lautenschlaeger J, Prell T, Grosskreutz J. Endoplasmic reticulum stress and the ER mitochondrial calcium cycle in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2012;13: 166-177.
33. Hu BY, Weick JP, Yu J et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA 2010; 107:4335-4340.
34. Pourquié O, ColteyM, BréantC et al. Control of somite patterning by signals from the lateral plate. Proc Natl Acad Sci USA 1995;92: 3219-3223.
35. Parr BA, Shea MJ, Vassileva G et al. Mouse Wnt genes exhibit discrete domains of expression in the early embryonic CNS and limb buds. Development 1993;119:247-261.
36. Aulehla A, Pourquié O. Signaling gradients during paraxial mesoderm development. Cold Spring Harb Perspect Biol 2010; 2:a000869.
37. Hofmann M, Schuster-Gossler K, Watabe-RudolphMet al. WNTsignaling, in synergy with T/TBX6, controls Notch signaling by regulating Dll1 expression in the presomitic mesoderm of mouse embryos. Genes Dev 2004; 18:2712-2717.
38. Zhang X, Ibrahimi OA, Olsen SK et al. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J Biol Chem 2006;281:15694-15700.
39. Kästner S, Elias MC, Rivera AJ et al. Gene expression patterns of the fibroblast growth factors and their receptors during myogenesis of rat satellite cells. J Histochem Cytochem 2000;48:1079-1096.
40. Marics I, Padilla F, Guillemot JF et al. FGFR4 signaling is a necessary step in limb muscle differentiation. Development 2002;129: 4559-4569.
41. Yu S, Zheng L, Trinh DK et al. Distinct transcriptional control and action of fibroblast growth factor receptor 4 in differentiating skeletal muscle cells. Lab Invest 2004;84: 1571-1580.
42. Fong AP, Yao Z, Zhong JW et al. Genetic and epigenetic determinants of neurogenesis and myogenesis. Dev Cell 2012;22:721-735.
43. Takemoto T, Uchikawa M, Yoshida M et al. Tbx6-dependent Sox2 regulation determines neural or mesodermal fate in axial stem cells. Nature 2011;470:394-398.